Clinical Trials Browser

Phase 4 × Recurrence × tocilizumab × Clear all

NCT06251076 2025-12-10

Plan Development for Giving Teclistamab in the Outpatient Setting

Phase 4 Recruiting

Multiple Myeloma, Neoplasms, Recurrence